Development of a diagnostic test system for early non-invasive detection of prostate cancer based on PCA3 mRNA levels in urine sediment using quantitative reverse transcription polymerase chain reaction (qRT-PCR)

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk

Volumn , Issue 5, 2013, Pages 45-51

  Pavlov, K A ^a   Shkoporov, A N ^b   Khokhlova, E V ^b   Korchagina, A A ^b   Sidorenkov, A V ^c   Grigoriev, M E ^b   Pushkar, D U ^c   Chekhonin, V P ^a  

^a Serbsky National Research Center   (Russian Federation)

^b PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^c A I EVDOKIMOV MOSCOW STATE UNIVERSITY OF MEDICINE AND DENTISTRY   (Russian Federation)

Author keywords

Biomarker; PCA3; Prostate cancer; Real time polymerase chain reaction; RT PCR

Indexed keywords

PROSTATE CANCER ANTIGEN 3, HUMAN; PROSTATE SPECIFIC ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; AGE; AGED; ARTICLE; BIOPSY; BLOOD; EARLY DIAGNOSIS; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STATISTICS; URINE;

ADULT; AGE FACTORS; AGED; ANTIGENS, NEOPLASM; BIOPSY; EARLY DETECTION OF CANCER; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84885921049     PISSN: 08696047     EISSN: 24143545     Source Type: Journal    
DOI: 10.15690/vramn.v68i5.662     Document Type: Article

References (12)

1. Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., Boyle P. Ann. Oncol. 2007; 18: 581-592.
2. Kok J.B., Verhaegh G.W., Roelofs R.W., Hessels D., Kieme-ney L.A., Aalders T.W., Swinkels D.W., Schalken J.A. Cancer Res. 2002; 62: 2695-2698.
3. Bussemakers M.J., van Bokhoven A., Verhaegh G.W., Smit F.P., Karthaus H.F., Schalken J.A., Debruyne F.M., Ru N.. Isaacs W.B. Cancer Res. 1999; 59 (23): 5975-5979.
4. Day J.R., Jost M., Reynolds M.A., Groskopf J., Rittenhouse H. Cancer Lett. 2011;301: 1-6.
5. Bourdoumis A., Papatsoris A.G., Chrisofos M., Efstathiou E., Skolarikos A., Deliveliotis C. Int. Braz. J. Urol. 2010; 36 (6): 665-668.
6. van Gils M.P., Hessels D., van Hooij O., Jannink S.A., Peelen W.P., Hanssen S.L., Witjes J.A., Cornel E.B., Karthaus H.F., Smits G.A., Dijkman G.A., Mulders P.F., Schalken J.A. Clin. Cancer Res. 2007; 13 (3): 939-943.
7. Fradet Y, Saad E, Aprikian A., Dessureault J., Elhilali M., Tmdel C, Masse B., Piche L., Chypre C. Urology. 2004; 64 (2): 311-315.
8. Tinzl M., Marberger M., Horvath S., Chypre C. Eur. Urol. 2004; 46 (2): 182-186.
9. Hessels D., Schalken J.A. Nat. Rev. Urol. 2009; 6 (5): 255-261.
10. Brawer M.K., Chetner M.P., Beatie J., Buchner D.M., Vessel-la R.L., Lange PH. J. Urol. 1992; 147(3 Pt. 2): 841-845.
11. Roobol M.J., Schroder F.H., van Leeuwen P., Wolters T., van den Bergh R.C., van Leenders G.J., Hessels D. Eur. Urol. 2010; 58 (4): 475-481.
12. Wang R., Chinnaiyan A.M., Dunn R.L., Wojno K.J., Wei J.T. Cancer. 2009; 115 (17): 3879-3886.